Dengue Fever Vaccine
Dengue fever vaccine is a vaccine that helps protect against dengue fever, a mosquito-borne viral infection common in tropical regions. The QDENGA® vaccine is recommended for children aged 4 years and older, as well as adults, including those with a history of dengue fever. The vaccination schedule consists of 2 doses administered 3 months apart. This vaccine is over 80% effective, reducing the risk of hospitalisation by up to 90%, and provides robust protection against all four dengue virus serotypes.
- Individuals with or without a history of dengue fever: Unlike previous vaccines, QDENGA® can be administered regardless of prior exposure to the virus.
- 2 doses, given 3 months apart.
You may experience mild side-effects following vaccination. Most side-effects last no more than a couple of days and are part of the immune system’s natural response to the vaccine.
Common reactions include:
- Pain, swelling and redness at the injection site
- Headache
- Fatigue
- Mild fever
- Muscle, body aches.
Serious reactions to vaccines are rare. If you have a reaction you think is severe or unexpected, contact our Preventive Medicine Centre straight away.
- This charge does not include consultation or injection costs.
Recommended Programmes
